Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Huoshanshi Capital

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 2
Average round size
The average size of a deal this fund participated in
Portfolio companies 2
Lead investments 0
Key employees Soon

Areas of investment

  • Life Science
  • Medical
  • Health Care
  • Health Diagnostics
  • Biotechnology

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Canrock Ventures Hicksville, New York, United States
Chuangzhi Capital -
CHUGIN LEASE Japan, Okayama, Okayama Prefecture
Dalian Juntai China, Dalian, Zhejiang
Dohold Capital China, Guangdong, Tianjin
Ensis Growth Fund Canada, Manitoba, Winnipeg
Full Commit Partners Japan, Tokyo
Hsin Investments -
Huijunfeng Zichan China, Shanghai
International Accelerator Austin, Texas, United States
Nantong Intelligent Manufacturing Industrial Investment fund China, Jiangsu, Rugao
NQV8 -
Rykadan Capital -
TR.PE Istanbul, Istanbul, Turkey
UP2398 California, Redwood City, United States
Westminster Growth Capital England, London, United Kingdom
Winona Capital Management Chicago, Illinois, United States
Wolfson Equities New York, New York, United States
Yidezhen Touzi China, Shanghai
Zephyr Peacock India Bengaluru, India, Karnataka

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Beijing Gene+ Technology

Health Care
Life Science
$30M14 Sep 2016 Changping District, Beijing, China

Geneplus-Beijing Co. Ltd.

Health Diagnostics
$30M09 Sep 2016 -


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Huoshanshi Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: